Vaxxinity, Inc.: Nasdaq/NYSE listing notice — Vaxxinity receives Nasdaq delisting notice for failure to meet minimum bid price rule

Vaxxinity, Inc.

Received Nasdaq notice on Feb 9, 2024, for non-compliance with minimum bid price of $1.00 per share.
Must regain compliance by August 7, 2024 (180-day compliance period).
Can regain compliance if closing bid price ≥ $1.00 for ten consecutive business days.
No immediate impact on listing; stock remains on Nasdaq Global Market during compliance period.
Company will monitor bid price and consider options to regain compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 1.0

Vaxxinity, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

February 9, 2024, Vaxxinity, Inc. (the “Company”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that the Company was no longer in compliance with Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”) with respect to its Class A Common Stock, which requires the Company to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Global Market (the “Notice”). The Company has until August 7, 2024, which is 180 calendar days from the date of the Notice (the “Compliance Period”), to regain compliance with the

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001562762-24-000025

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.